Mednet Logo
HomeDermatology
Dermatology

Dermatology

Clinical insights on skin conditions, dermatologic procedures, and treatment approaches from practicing dermatologists.

Recent Discussions

Do you prescribe fluocinolone in peanut oil in patients with peanut allergies?

2
3 Answers

Mednet Member
Mednet Member
Dermatology · Duke Health

Yes. Paller et al., PMID 12664021

How do you manage new-onset vitiligo in a patient on immune checkpoint inhibitors?

2
3 Answers

Mednet Member
Mednet Member
Medical Oncology · The Ohio State University Comprehensive Cancer Center / James Cancer Hospital and Solove Research Institute

Vitiligo is quite often (not always) associated with good long-term clinical outcomes for melanoma patients treated with immune checkpoint therapy. It is an indication of the activity of the drug, as it is due to unleashing of the T-cells’ attack on the bystander melanocytes in addition to melanoma ...

What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

As is true for most of us, I have limited direct clinical experience treating patients with Blau Syndrome. I have treated members of several families and am convinced that corticosteroids are effective and fraught with long-term toxicity. As the question implies, a TNF inhibitor (specifically a mono...

Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?

6
1 Answers

Mednet Member
Mednet Member
Dermatology · Duke Health

This is a really broad question given how many biologics exist now, but the answer is likely yes, given its outstanding safety profile. I have used it concurrently with other biologics on many occasions without any issues so far. As concurrent use increases, we may find out more if there are any "tw...

How often do you draw screening ANAs for discoid lupus?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Because a positive ANA is associated with an increased risk of progression to SLE in patients with discoid lupus, I routinely check an ANA at the initial visit in virtually all patients. If negative, I repeat it only if new symptoms concerning systemic involvement arise (e.g., joint pain, cytopenias...

Do certain subtypes of BCC respond better to hedgehog pathway inhibitors?

1 Answers

Mednet Member
Mednet Member
Dermatology · Geisinger Commonwealth Medical College

I have found that the larger the BCC, the more dramatic the response (unfortunately, not all tumors respond). These are invariably of the nodular/infiltrative subtypes for which hedgehog inhibitors are indicated.

What topical therapies have you found most effective for managing scalp psoriasis?

1 Answers

Mednet Member
Mednet Member
Dermatology · University of Pennsylvania Perelman School of Medicine

For tough scalp psoriasis, I use an old regimen. 10% LCD 2% Sal acid in olive oil applied tiw x 1 hour under a shower cap. This is then washed out with a zinc-based shampoo followed by the application of a potent topical steroid. This is labor intensive but can be incredibly effective and sometimes ...

How do you counsel patients with dermatomyositis on sun protection?

2
3 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

We make sure patients know that sun exposure can trigger flares, so we strongly recommend staying out of direct sunlight between 10 AM and 4 PM, using broad spectrum, SPF30+ sunscreen daily even when indoors (as UVA can penetrate through windows), and wearing sun protective clothing (ideally UPF-rat...

How would you approach adjuvant RT for porocarcinoma of the face?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Medical University of South Carolina (Charleston)

The reported outcomes after surgery in the published literature are all over the place. With some saying surgery alone is adequate and others reporting that these have a high incidence of local, in-transit, and regional recurrence. I tend to treat these with Merkel cell carcinoma volumes.

How would you palliate a large, symptomatic vaginal melanoma recurrence with limited small pelvic lymph node metastases?

5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Palliation. Treat problems that are symptomatic. No expensive systemic work up. Pall RT to the pelvis if it’s symptomatic. 30 Gy/10 fractions, 25 Gy/5 fractions, or 20 Gy/2 fractions with a 1 week inter-fraction interval. Apologize for the lengthy response.